The Clorox Company (NYSE:CLX) Shares Sold by Carlton Hofferkamp & Jenks Wealth Management LLC

Carlton Hofferkamp & Jenks Wealth Management LLC lessened its stake in The Clorox Company (NYSE:CLX) by 4.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,290 shares of the company’s stock after selling 160 shares during the quarter. Carlton Hofferkamp & Jenks Wealth Management LLC’s holdings in Clorox were worth $534,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Catalyst Capital Advisors LLC bought a new stake in shares of Clorox during the 3rd quarter valued at about $54,000. Los Angeles Capital Management LLC grew its position in shares of Clorox by 5.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after buying an additional 10,149 shares during the last quarter. Advisors Asset Management Inc. grew its position in shares of Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock valued at $4,865,000 after buying an additional 9,037 shares during the last quarter. Natixis Advisors LLC grew its position in shares of Clorox by 8.3% during the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after buying an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Clorox by 1.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after buying an additional 13,038 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 0.3 %

CLX stock opened at $155.90 on Tuesday. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The firm has a market cap of $19.21 billion, a PE ratio of 42.60, a P/E/G ratio of 2.62 and a beta of 0.42. The firm has a 50 day simple moving average of $156.73 and a 200 day simple moving average of $160.44. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the firm posted $2.16 earnings per share. Equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.13%. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Analysts Set New Price Targets

CLX has been the subject of a number of recent research reports. DA Davidson lowered their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. JPMorgan Chase & Co. upped their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Finally, Barclays upped their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus target price of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.